Schaper Benz & Wise Investment Counsel Inc. WI Raises Holdings in Stryker Corporation (SYK)
Schaper Benz & Wise Investment Counsel Inc. WI boosted its position in shares of Stryker Corporation (NYSE:SYK) by 1.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 120,417 shares of the medical technology company’s stock after purchasing an additional 1,475 shares during the period. Stryker Corporation makes up 2.7% of Schaper Benz & Wise Investment Counsel Inc. WI’s holdings, making the stock its 5th biggest holding. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Stryker Corporation were worth $17,102,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the company. Stifel Financial Corp grew its holdings in shares of Stryker Corporation by 32.2% in the first quarter. Stifel Financial Corp now owns 115,452 shares of the medical technology company’s stock valued at $15,213,000 after purchasing an additional 28,103 shares in the last quarter. Cibc World Markets Corp grew its holdings in shares of Stryker Corporation by 51.7% in the first quarter. Cibc World Markets Corp now owns 32,328 shares of the medical technology company’s stock valued at $4,256,000 after purchasing an additional 11,011 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Stryker Corporation in the first quarter valued at approximately $263,000. Papp L Roy & Associates grew its holdings in shares of Stryker Corporation by 467.3% in the first quarter. Papp L Roy & Associates now owns 20,763 shares of the medical technology company’s stock valued at $2,733,000 after purchasing an additional 17,103 shares in the last quarter. Finally, BB&T Securities LLC grew its holdings in shares of Stryker Corporation by 3.9% in the first quarter. BB&T Securities LLC now owns 8,371 shares of the medical technology company’s stock valued at $1,102,000 after purchasing an additional 313 shares in the last quarter. 74.13% of the stock is currently owned by institutional investors and hedge funds.
A number of research analysts recently weighed in on SYK shares. BMO Capital Markets restated a “hold” rating and issued a $140.00 price objective on shares of Stryker Corporation in a report on Tuesday, July 11th. Zacks Investment Research upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price target for the company in a report on Monday, July 17th. Royal Bank Of Canada boosted their price target on shares of Stryker Corporation from $140.00 to $155.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Oppenheimer Holdings, Inc. set a $148.00 price target on shares of Stryker Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Finally, Stifel Nicolaus boosted their price target on shares of Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $151.52.
ILLEGAL ACTIVITY NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2017/11/08/schaper-benz-wise-investment-counsel-inc-wi-raises-holdings-in-stryker-corporation-syk.html.
Stryker Corporation (NYSE SYK) traded up $0.29 during trading hours on Wednesday, hitting $156.51. 297,703 shares of the stock were exchanged, compared to its average volume of 1,269,563. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. Stryker Corporation has a fifty-two week low of $106.48 and a fifty-two week high of $160.62. The firm has a market cap of $58,250.08, a PE ratio of 24.67, a PEG ratio of 2.45 and a beta of 0.79.
Stryker Corporation (NYSE:SYK) last issued its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.97 billion. Stryker Corporation had a net margin of 14.67% and a return on equity of 24.11%. The firm’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.39 EPS. analysts forecast that Stryker Corporation will post 6.47 EPS for the current year.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the sale, the insider now directly owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 7.40% of the stock is currently owned by corporate insiders.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.